Renflexis infliximab-abda 100 mg lyophilized powder for Injection Images
Generic Name: infliximab
This medication has been identified as Renflexis infliximab-abda 100 mg lyophilized powder for Injection. It is supplied by Merck.
Renflexis is used in the treatment of Ulcerative Colitis; Crohn's Disease; Crohn's Disease, Active; Ankylosing Spondylitis; Inflammatory Bowel Disease and belongs to the drug class TNF alfa inhibitors. There is no proven risk in humans during pregnancy. Renflexis infliximab-abda 100 mg lyophilized powder for Injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Renflexis
- Generic Name
- infliximab
- Strength
- infliximab-abda 100 mg lyophilized powder for Injection
- Availability
- Prescription only
- Drug Class
- TNF alfa inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Merck
- Manufacturer
- Samsung Bioepis Co., Ltd.
- National Drug Code (NDC)
- 00006-4305
More about Renflexis (infliximab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
- En español
Patient resources
- Renflexis drug information
- Renflexis (Infliximab Intravenous) (Advanced Reading)
- Renflexis (Infliximab-abda Intravenous) (Advanced Reading)
Other brands
Remicade, Inflectra, Avsola, Zymfentra, Ixifi
Professional resources
Other brands
Remicade, Inflectra, Avsola, Zymfentra
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.